Illumina, Inc (ILMN) TD Cowen 46th Annual Health Care Conference 2026
Illumina, Inc (NASDAQ: ILMN) FY 2026 Corporate Conference
Illumina, Inc (ILMN) Sec Form 10K
Illumina, Inc (NASDAQ: ILMN) Sec Form 10K
Illumina, Inc (ILMN) AI, Genomics, and CRISPR Signal a New Phase of Biological Innovation
Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release
Illumina, Inc (ILMN) Sec Form 8K
Illumina, Inc (NASDAQ: ILMN) Sec Form 8K
ADVERTISEMENT
Illumina, Inc (ILMN) Q2 2025 Earnings Call Transcript
Illumina, Inc (NASDAQ: ILMN) Q2 2025 Earnings Call dated Jul. 31, 2025 Corporate Participants: Brian Blanchett — Head of Investor Relations Jacob Thaysen — Chief…
Illumina, Inc (ILMN) Q3 2025 Earnings Call Transcript
Illumina, Inc (NASDAQ: ILMN) Q3 2025 Earnings Call dated Oct. 30, 2025 Corporate Participants: Conor McNamara — Vice President, Investor Relations Jacob Thaysen — Chief…
Market News
Illumina (ILMN) expects adjusted EPS of approximately $4.50 for FY25
Biotechnology company Illumina, Inc. (NASDAQ: ILMN) has issued fresh earnings guidance for fiscal 2025, to reflect tariff-related challenges to export. The company said it expects…
Illumina Inc (ILMN) Q1 2023 Earnings Call Transcript
Illumina Inc (NASDAQ: ILMN) Q1 2023 earnings call dated Apr. 25, 2023 Corporate Participants: Salli Schwartz — Vice President of Investor Relations Francis deSouza — Chief Executive Officer Joydeep…
ADVERTISEMENT
Illumina Inc (ILMN) Q4 2022 Earnings Call Transcript
Illumina Inc (NASDAQ:ILMN) Q4 2022 Earnings Call dated Feb. 07, 2023. Corporate Participants: Salli Schwartz — Vice-President of Investor Relations Francis deSouza — President and Chief Executive Officer Joydeep…
Illumina, Inc (ILMN) Q3 2022 Earnings Call
Illumina, Inc (NASDAQ: ILMN) Q3 2022 Earnings Conference